Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
BPC-157&TB-500 20mg Pen device with Cartridge Box (R&D Only) bulk supplier for pharma manufacturers

Bpc-157&Tb-500 20Mg Pen Device With Cartridge Box (R&D Only) 10 mg + 10 mg Suppliers & Bulk Manufacturers

Available Forms: Prefilled syringe

Available Strengths: 10 mg + 10 mg

Reference Brands: Generic formulations

Category: R&D

Bpc-157&Tb-500 20Mg Pen Device With Cartridge Box (R&D Only) is a R&D product available as Prefilled syringe in strengths 10 mg + 10 mg. It corresponds to the reference brand Generic formulations. Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

BPC-157 / TB-500 is a synthetic peptide intended for research and laboratory use only. It is not approved for human consumption or therapeutic use. Widely used in experimental studies, it helps researchers explore tissue repair, regeneration, and related biological processes under controlled laboratory conditions.

Bpc-157&Tb-500 20Mg Pen Device With Cartridge Box (R&D Only) — third party manufacturing & bulk supply

Bpc-157&Tb-500 20Mg Pen Device With Cartridge Box (R&D Only) 10 mg + 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Bpc-157&Tb-500 20Mg Pen Device With Cartridge Box (R&D Only) listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Bpc-157&Tb-500 20Mg Pen Device With Cart... →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

BPC-157 & TB-500 is positioned for research and laboratory applications related to muscle recovery, tissue repair mechanisms, and regenerative process studies. It is commonly associated with research in strength support, musculoskeletal recovery pathways, and cellular repair processes.

BPC-157 is a synthetic peptide known as Body Protection Compound-157, while TB-500 is a synthetic peptide fragment derived from Thymosin Beta-4. Both peptides are produced using controlled peptide synthesis technology for research-grade applications.

BPC-157 & TB-500 is available in INN generic formulation and does not have an approved proprietary trade name.

BPC-157 & TB-500 is manufactured by Shilai Healthcare.

The complete generic names are Body Protection Compound-157 (BPC-157) and Thymosin Beta-4 fragment (TB-500).

BPC-157 & TB-500 is available in INN generic formulation.

BPC-157 & TB-500 is manufactured by Shilai Healthcare.

Related Products

Type A Botulinum Toxin Injection (R&D Only)

Strength:
150 IU

Form: Injection

Reference Brands: Generic formulations

View Details
Mots‑C Injection (R&D Only)

Strength:
10 mg

Form: Injection

Reference Brands: Generic formulations

View Details
Bpc-157&Tb-500 Injection (R&D Only)

Strength:
20 mg

Form: Injection

Reference Brands: Generic formulations

View Details
Nad⁺ 500Mg Injection (R&D Only)

Strength:
500 mg

Form: Injection

Reference Brands: Generic formulations

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.